Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (projected)
Funding Amounts: Award size and total program funding not yet specified; details to be announced in future solicitation.
Summary: Supports early-stage translational research for assay development and identification of potential therapeutic agents for neurological and related disorders.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.